Loading
Life sciences · Journal article
Acs Nano · November 2, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Abstract Inflammatory breast cancer (IBC) is a highly aggressive breast cancer subtype characterized by diffuse, biologically invasive growth and poorly defined tissue boundaries, resulting in a high mortality rate even after multimodal treatment. Here, we report an intracellular polymerization-induced self-assembly (PISA) strategy that constructs mechanically active peptide nanosheets. Upon 365 nm UV irradiation, the photoinitiator Irgacure 2959 (I2959) initiates intracellular PISA of HisMAm in IBC cells. The corresponding nanosheets prepared in vitro exhibit a thickness of ∼30 nm and a wet-state apparent Young’s modulus of 8.02 ± 0.43 MPa. These nanosheets act through two coordinated materials-cell interactions: (i) increasing cellular viscosity and spatially associating with the actin cytoskeleton, suppressing cell migration and invasion; and (ii) accumulating in the endoplasmic reticulum and eliciting paraptosis-like cell death. In a subcutaneous IBC xenograft model, localized fiber-assisted light activation achieves 72.2% tumor growth inhibition without overt systemic toxicity. Overall, this work establishes intracellular PISA as a spatiotemporally controlled materials strategy for localized IBC treatment.